US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Liquidia Corporation - Common Stock
(NQ:
LQDA
)
28.64
+0.65 (+2.32%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Liquidia Corporation - Common Stock
< Previous
1
2
3
4
Next >
Liquidia Provides Update on Hatch-Waxman Litigation Tied to ‘327 Patent
September 30, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis
September 03, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia to Present Posters at the European Respiratory Society (ERS) 2026 Congress
September 02, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference
September 01, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia to Present Clinical Data from ASCENT Trial at the CHEST 2025 Annual Meeting
September 29, 2025
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation Reports Second Quarter 2026 Financial Results
August 12, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation to Report Second Quarter 2026 Financial Results on August 12, 2026
July 29, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions
June 11, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index
June 08, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference
May 27, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation Reports First Quarter 2026 Financial Results
May 11, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation to Participate in Upcoming Investor Conferences
May 06, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026
May 04, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation to Participate in Upcoming Investor Conferences
April 07, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
March 05, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026
February 26, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia to Present Clinical Data Across Its Portfolio at the Pulmonary Vascular Research Institute 2026 Annual Congress
January 27, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation Announces Preliminary Full-Year 2025 YUTREPIA Net Sales and Corporate Update
January 09, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference
January 07, 2026
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences
November 03, 2025
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 03, 2025
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025
October 27, 2025
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation to Host R&D Day in New York City on October 28, 2025
October 07, 2025
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) Symposium
September 11, 2025
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference
August 27, 2025
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 12, 2025
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025
August 05, 2025
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™
June 23, 2025
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD
June 02, 2025
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference
May 28, 2025
From
Liquidia Technologies, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
